Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Tempus AI, Inc. Class A ( (TEM) ).
On June 30, 2025, Tempus AI, Inc. announced a proposed offering of $400 million in Convertible Senior Notes due in 2030, with an option for an additional $60 million. The proceeds are intended to repay outstanding term loans, reduce interest expenses, and support general corporate purposes, including strategic investments. The offering aims to optimize Tempus’s capital structure and enhance financial flexibility, potentially impacting the market price of its Class A common stock and the conversion price of the Notes.
The most recent analyst rating on (TEM) stock is a Buy with a $45.00 price target. To see the full list of analyst forecasts on Tempus AI, Inc. Class A stock, see the TEM Stock Forecast page.
Spark’s Take on TEM Stock
According to Spark, TipRanks’ AI Analyst, TEM is a Neutral.
Tempus AI’s overall score reflects its robust revenue growth and strategic partnerships, counterbalanced by financial instability, negative cash flows, and ongoing losses. The technical outlook is moderately positive, yet valuation concerns persist due to unprofitability.
To see Spark’s full report on TEM stock, click here.
More about Tempus AI, Inc. Class A
Tempus AI, Inc. is a technology company that advances precision medicine through the application of artificial intelligence in healthcare. It provides AI-enabled precision medicine solutions to physicians, facilitating the discovery, development, and delivery of optimal therapeutics with a focus on personalized patient care.
Average Trading Volume: 13,234,661
Technical Sentiment Signal: Strong Buy
Current Market Cap: $10.29B
For detailed information about TEM stock, go to TipRanks’ Stock Analysis page.